INS and metabolic syndrome: MNPs serve as carriers for EDCs like bisphenol A (BPA) and phthalates, which disrupt the HPT and HPG axes. They alter hormone receptor activity, reduce thyroid hormone (T3, T4) levels, impair insulin signaling, promote adipogenesis, and induce hypertension and dyslipidemia.